Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GM1 ganglioside is a glycosphingolipid that functions as a receptor involved in neuronal plasticity, repair, neuroregeneration, and signal transduction. It acts as a high-affinity receptor for cholera toxin and certain viruses, and is implicated in various neurological and autoimmune disorders. It modulates membrane organization and influences properties of membrane enzymes and receptors. Exogenous administration has shown therapeutic effects in neurodegenerative disease models.
Modulation of membrane organization and influencing properties of membrane enzymes and receptors, amplification of neurotrophic factor responses, high-affinity binding site for toxins and viruses.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GM1 ganglioside receptor.